Takahashi Kenzo

写真a

Title

Professor

Researcher Number(JSPS Kakenhi)

80291425
To the head of this page.▲

Current Affiliation Organization 【 display / non-display 】

  • Duty   University of the Ryukyus   Graduate School of Medicine   Professor  

To the head of this page.▲

External Career 【 display / non-display 】

  • 2010.04
    -
    2016.03

    University of the Ryukyus, Graduate School of Medicine, Associate Professor  

  • 2016.04
    　
    　

     

To the head of this page.▲

Published Papers 【 display / non-display 】

  • Massive squamous cell carcinoma arising from hidradenitis suppurativa with marked hypercalcemia and neutrophilia.

    Uehara H, Yamaguchi S, Fukai K, Omine T, Miyagi T, Takahashi K

    JAAD case reports ( JAAD Case Reports )  29   9 - 10   2022.11 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

    • Access this article
      DOI
    • Search related information
      PubMed

  • Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan.

    Hayashi N, Hayama K, Takahashi K, Kurokawa I, Okazaki M, Kashiwagi T, Iwashita E, Terui T

    The Journal of dermatology   49 ( 4 ) 411 - 421   2022.04

    Type of publication: Research paper (scientific journal)

    • Access this article
      DOI
    • Search related information
      PubMed

  • Establishment of the Western Japan Psoriasis Registry and first cross-sectional analysis of registered patients

    Tsuruta N.

    Journal of Dermatology ( Journal of Dermatology )  48 ( 11 ) 1709 - 1718   2021.11 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

    • Access this article
      DOI

  • Efficacy and safety of a dimethicone lotion in patients with pyrethroid-resistant head lice in an epidemic area, Okinawa, Japan.

    Yamaguchi S, Yasumura R, Okamoto Y, Okubo Y, Miyagi T, Kawada H, Takahashi K

    The Journal of dermatology ( Journal of Dermatology )  48 ( 9 ) 1343 - 1349   2021.09 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

    • Access this article
      DOI
    • Search related information
      PubMed

  • Multi-institutional Joint Survey of Tuberculosis Countermeasures Against Psoriasis Biologics Treatment

    Kaneko Sakae, Tsuruta Noriko, Ito Kotaro, Yamaguchi Kazuki, Miyagi Takuya, Takahashi Kenzo, Higashi Yuko, Morizane Shin, Nomura Hayato, Yamaguchi Michiya, Hino Ryosuke, Sawada Yu, Nakamura Motonobu, Ohyama Bungo, Ohata Chika, Yonekura Kentaro, Hayashi Hiroaki, Yanase Tetsuji, Matsuzaka Yuki, Sugita Kazunari, Kikuchi Satoko, Mitoma Chikage, Nakahara Takeshi, Furue Masutaka, Okazaki Fusako, Koike Yuta, Imafuku Shinichi, The Western Japan Inflammatory Disease Research Group

    The Japanese Journal of Dermatology ( Japanese Dermatological Association )  131 ( 6 ) 1525 - 1532   2021.05

    Type of publication: Research paper (scientific journal)

    　View Summary

    <p>The purpose of this study was to determine how psoriastic patients were screened for tuberculosis control during the use of biologic agents, and to discover which modality was employed if a diagnosis of latent tuberculosis infection (LTBI) was made. the subjects were 1,117 patients who visited 18 participating institutions from 2010 to march 2017 and received biologics with a diagnosis of psoriasis. of 167 patients treated with LTBI, 166 were given isoniazid for a median duration of 232 days. adverse effects of LTBI treatment occurred in 23 patients (15%), liver damage, occurring in 19 patients (83%), the most common adverse effect. these careful measures achieved a very low incidence (0.2%) of active tuberculosis.</p>

display all >>

To the head of this page.▲

Other Papers 【 display / non-display 】

To the head of this page.▲